Management of Persistent Scotomas after Photocoagulation

Introduction to Expected Outcomes

• Scotomas after photocoagulation are considered an anticipated side effect rather than a complication, although this fact is not associated with a specific citation.

Follow-up and Monitoring

• For patients with persistent scotomas after photocoagulation, recommended follow-up testing includes visual field testing, contrast sensitivity testing, Amsler grid screening, and OCT imaging, with consideration for follow-up OCT in 3-6 months to monitor for any delayed structural changes, according to a study published in 2020 1
• Red flags requiring more urgent evaluation include new symptoms or change in symptoms, peripheral visual field loss beyond expected treatment areas, decreased visual acuity not explained by the treatment, and development of subretinal fluid beyond the edge of treatment, as noted in a study published in 2020 1
• If scotomas worsen rather than improve over time, if new scotomas develop in untreated areas, if OCT begins to show abnormalities on follow-up imaging, or if there is evidence of choroidal neovascularization, additional intervention should be considered, as suggested in a study published in 2020 1

Patient Education and Reassurance

• Patients should be reassured that scotomas are an expected side effect of photocoagulation and that normal OCT findings are positive and suggest no structural complications, although this fact is not associated with a specific citation.

Factors Influencing Outcome

• The American Academy of Ophthalmology recommends peripheral scatter laser (PRP) for neovascularization complications such as vitreous hemorrhage or iris neovascularization, as demonstrated by the BVOS (Branch Vein Occlusion Study) 2
• The BVOS (Branch Vein Occlusion Study) showed that grid laser treatment was effective for macular edema with an acceptable side effect profile 2
• Modern studies have shown that adding laser to anti-VEGF treatments did not improve outcomes in retinal vein occlusions 2
• In the treatment of retinal vein occlusions, peripheral scatter laser photocoagulation has been used safely for decades 2
• The American Academy of Ophthalmology recommends using minimum effective energy levels for photocoagulation and careful control of power settings to minimize the risk of bleeding complications 3, 4, 5, 6, 7
• The risk of nerve damage with laser photocoagulation is documented, primarily in the form of permanent scotomas, though severe optic nerve damage is rare when proper techniques and energy settings are used 2
• Peripheral scotomas are generally less symptomatic than those closer to the fovea, and far peripheral treatments typically result in minimal visual impact for patients 2
• Severe bleeding after laser photocoagulation is rare but can necessitate blood transfusion or surgical intervention, with the American College of Obstetricians and Gynecologists recommending prompt recognition and management of bleeding complications 3
• Management of bleeding after laser photocoagulation may involve pressure application, additional laser treatment, blood transfusion, or surgical intervention, depending on the severity of the bleeding, as recommended by the American College of Obstetricians and Gynecologists 3
• Introduction or enlargement of scotomas is an anticipated side effect, not a complication, according to the American Academy of Ophthalmology 6
• Higher energy settings cause more permanent damage and potentially more persistent scotomas, as reported by the American Academy of Ophthalmology 5, 7, 8
• Treatment location, proximity to the fovea (within 500μm is high-risk), affects the likelihood and severity of scotomas, as stated by the American Academy of Ophthalmology 5, 7, 8, 9

Treatment and Management

• Initial evaluation should be performed 3-4 months after photocoagulation, including visual field testing, OCT imaging, contrast sensitivity testing, and Amsler grid screening for laser-related scotomas, as recommended by the American Academy of Ophthalmology 8, 7, 2
• Patients should be monitored for potential complications, including signs of choroidal neovascularization, and scheduled for post-treatment evaluation within 3-4 months of laser surgery, as recommended by the American Academy of Ophthalmology 9
• Intraocular pressure (IOP) should be checked immediately prior to surgery and within 30 minutes to 2 hours after surgery, with a follow-up examination within 6 weeks of surgery or sooner if there is concern about IOP-related damage, as recommended by the American Academy of Ophthalmology 7, 10
• Patients may experience an IOP reduction of approximately 20-30% from baseline, with potential complications including temporary IOP spikes in 4.5-27% of cases, and mild anterior chamber inflammation, which typically resolves within the three-month monitoring period 10
• The American Academy of Ophthalmology also recommends setting appropriate patient expectations regarding the timeline for potential improvement (6-12 months) 7
• Conventional photocoagulation carries a risk of "symptomatic paracentral scotoma", which may persist but can show gradual reduction in size or intensity over 6-12 months, in patients undergoing photocoagulation for conditions like diabetic macular edema, according to the American Academy of Ophthalmology 8, 7
• Subthreshold diode laser photocoagulation shows better functional outcomes with less risk of persistent scotomas compared to conventional threshold laser, according to the American Academy of Ophthalmology 7
• Micropulse laser technique can significantly reduce paracentral scotomas over time, as noted by the American Academy of Ophthalmology 7
• Argon laser treatment should be performed with careful control of power settings (lower than 20-90 W) and wavelength range (448-514.5 nm) to minimize damage to surrounding tissues, as recommended by the American Academy of Ophthalmology 11, 12